EDIT vs KMI · rev $32.3M vs P/E 24, $62.53B cap
Editas Medicine Inc (EDIT) versus Kinder Morgan Inc (KMI) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Kinder Morgan Inc (KMI) is a oil & gas midstream company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
KMI does not have a complete income-statement cache yet.
EDIT currently screens at market cap $375.2M. KMI currently screens at market cap $62.53B and trailing P/E 24.2.
Not investment advice. Open the EDIT and KMI stock pages for the full models.
Not investment advice.